Literature DB >> 19870200

STUDIES ON MENINGOCOCCUS INFECTION : III. THE ANTIGENIC COMPLEX OF THE MENINGOCOCCUS-A TYPE-SPECIFIC SUBSTANCE.

G Rake1, H W Scherp.   

Abstract

Three fractions have been isolated from autolysates of the meningococcus. Of these, one, the type-specific substance, has been described in detail. The same type-specific substance appears to be present in Type I and Type III organisms, but a substance differing at least serologically has been obtained from Type II strains. Detailed chemical analysis of both of the type-specific substances thus far isolated is being carried out and will be the subject of a later paper.

Year:  1933        PMID： 19870200      PMCID： PMC2132305          DOI： 10.1084/jem.58.3.341

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  5 in total

1.  STUDIES ON MENINGOCOCCUS INFECTION : II. MONOVALENT DIAGNOSTIC SERA PREPARED FROM "FRESH" AND "STOCK" STRAINS.

Authors:  G Rake
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

2.  STUDIES ON MENINGOCOCCUS INFECTION : I. BIOLOGICAL PROPERTIES OF "FRESH" AND "STOCK" STRAINS OF THE MENINGOCOCCUS.

Authors:  G Rake
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

3.  FURTHER STUDIES ON BACTERIAL HYPERSUSCEPTIBILITY. II.

Authors:  H Zinsser; J T Parker
Journal:  J Exp Med       Date:  1923-01-31       Impact factor: 14.307

4.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : III. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE SPECIES-SPECIFIC SUBSTANCE.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-02-29       Impact factor: 14.307

5.  A SEROLOGICAL STUDY OF THE POLYSACCHARIDES OF MENINGOCOCCUS, B. ANTHRACIS, B. PROTEUS, B. SUBTILIS AND B. MESENTERICUS.

Authors:  J Zozaya
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307
  5 in total
  7 in total

1.  Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.

Authors:  M A Westerink; A A Campagnari; M A Wirth; M A Apicella
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

2.  STUDIES ON MENINGOCOCCUS INFECTION : X. A FURTHER NOTE ON THE PRESENCE OF MENINGOCOCCUS PRECIPITINOGENS IN THE CEREBROSPINAL FLUID.

Authors:  H E Alexander; G Rake
Journal:  J Exp Med       Date:  1937-02-28       Impact factor: 14.307

3.  STUDIES ON MENINGOCOCCUS INFECTION : V. THE PRESENCE OF MENINGOCOCCUS PRECIPITINOGENS IN THE CEREBROSPINAL FLUID.

Authors:  G Rake
Journal:  J Exp Med       Date:  1933-08-31       Impact factor: 14.307

4.  STUDIES ON MENINGOCOCCUS INFECTION : IV. THE ANTIGENIC COMPLEX OF THE MENINGOCOCCUS-GROUP-SPECIFIC CARBOHYDRATE AND PROTEIN FRACTIONS.

Authors:  G Rake; H W Scherp
Journal:  J Exp Med       Date:  1933-08-31       Impact factor: 14.307

5.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

6.  STUDIES ON MENINGOCOCCUS INFECTION : IX. STANDARDIZATION AND CONCENTRATION OF ANTIMENINGOCOCCUS HORSE SERUM (TYPE I).

Authors:  H W Scherp; G Rake
Journal:  J Exp Med       Date:  1936-03-31       Impact factor: 14.307

7.  STUDIES ON MENINGOCOCCUS INFECTION : VIII. THE TYPE I SPECIFIC SUBSTANCE.

Authors:  H W Scherp; G Rake
Journal:  J Exp Med       Date:  1935-05-31       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.